Related references
Note: Only part of the references are listed.Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
Willi Sauerbrei et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
Willi Sauerbrei et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Mortality of breast cancer in Taiwan, 1971-2010: Temporal changes and an age-period-cohort analysis
M. -L. Ho et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2015)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)
Breast Cancer Statistics, 2013
Carol DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Upregulation of Focal Adhesion Kinase by 14-3-3ε via NFκB Activation in Hepatocellular Carcinoma
Bor-Sheng Ko et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
14-3-3ε Overexpression Contributes to Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma
Tzu-An Liu et al.
PLOS ONE (2013)
The Clinicopathologic Features of YWHAE-FAM22 Endometrial Stromal Sarcomas: A Histologically High-grade and Clinically Aggressive Tumor
Cheng-Han Lee et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Proteomic profiling of follicular and papillary thyroid tumors
Anastasios Sofiadis et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Clinical implication of 14-3-3 epsilon expression in gastric cancer
Mariana Ferreira Leal et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Overexpression of 14-3-3ε predicts tumour metastasis and poor survival in hepatocellular carcinoma
Bor-Sheng Ko et al.
HISTOPATHOLOGY (2011)
The Prognostic Value of 14-3-3 Isoforms in Vulvar Squamous Cell Carcinoma Cases: 14-3-3β and ε Are Independent Prognostic Factors for These Tumors
Zhihui Wang et al.
PLOS ONE (2011)
14-3-3epsilon contributes to tumour suppression in laryngeal carcinoma by affecting apoptosis and invasion
Xing-Hua Che et al.
BMC CANCER (2010)
14-3-3ζ as a prognostic marker and therapeutic target for cancer
Christopher L. Neal et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
M. Elizabeth H. Hammond et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
14-3-3τ Regulates Ubiquitin-Independent Proteasomal Degradation of p21, a Novel Mechanism of p21 Downregulation in Breast Cancer
Bing Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
14-3-3ζ Overexpression Defines High Risk for Breast Cancer Recurrence and Promotes Cancer Cell Survival
Christopher L. Neal et al.
CANCER RESEARCH (2009)
Identification of new genes associated with breast cancer progression by gene expression analysis of predefined sets of neoplastic tissues
Daniela Cimino et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Nonsteroidal anti-inflammatory drugs induce colorectal cancer cell apoptosis by suppressing 14-3-3ε
Jun-Yang Liou et al.
CANCER RESEARCH (2007)
Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry
Da-Qiang Li et al.
PROTEOMICS (2006)
14-3-3 proteins: A historic overview
Alastair Aitken
SEMINARS IN CANCER BIOLOGY (2006)
Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues
WQ Qi et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Understanding breast cancer risk - where do we stand in 2005?
RG Dumitrescu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2005)
Proteomic analysis of ductal carcinoma of the breast using laser capture microdissection, LC-MS, and 16O/18O isotopic labeling
L Zang et al.
JOURNAL OF PROTEOME RESEARCH (2004)
Epidermal growth factor receptor in non-small-cell lung carcinomas:: Correlation between gene copy number and protein expression and impact on prognosis
FR Hirsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Tenascin-C signaling through induction of 14-3-3 tau
D Martin et al.
JOURNAL OF CELL BIOLOGY (2003)
Mammalian and yeast 14-3-3 isoforms form distinct patterns of dimers in vivo
M Chaudhri et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Significance of 14-3-3 self-dimerization for phosphorylation-dependent target binding
YH Shen et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants.
A Aitken
PLANT MOLECULAR BIOLOGY (2002)
Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease
V Beral et al.
LANCET (2001)
Role of the β isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation
Y Takihara et al.
CARCINOGENESIS (2000)
Share Paper
